CIK: 1376847 - Address: C/O Ambrx Biopharma, Inc., 10975 N Torrey Pines Road, La Jolla, CA 92037
19 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret1131-2-417-1912319
P%wins33033100333339
S%ret115-11-3-10-16-11-7
S%wins60608040606761

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/31/23 17:00
10/27/23
AMAMAmbrx Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagO'Connor Daniel J.CADOP,CEOS-4919.820-50-13343D
6/2/22 16:29
6/1/22
SEELSeelos Therapeutics, Inc.NVHealthDrugPharmaceutical PreparationsO'Connor Daniel J.NYDP100.6118016New16D
5/4/21 20:00
4/30/21
ONCSOncosec Medical IncNVHealthDrugPharmaceutical PreparationsO'Connor Daniel J.NJDOCEO,PS-154.860-3-396D
2/2/21 20:00
2/1/21
ONCSOncosec Medical IncNVHealthDrugPharmaceutical PreparationsO'Connor Daniel J.NJDOCEO,PS-267.710-3-399D
11/3/20 20:04
11/2/20
ONCSOncosec Medical IncNVHealthDrugPharmaceutical PreparationsO'Connor Daniel J.NJDOCEO,PS-123.790-3-3103D
8/4/20 21:21
7/31/20
ONCSOncosec Medical IncNVHealthDrugPharmaceutical PreparationsO'Connor Daniel J.NJDOCEO,PS-134.200-3-3106D
5/4/20 18:07
4/30/20
ONCSOncosec Medical IncNVHealthDrugPharmaceutical PreparationsO'Connor Daniel J.NJDOCEO,PS-61.790-3-563D
2/3/20 20:00
1/31/20
ONCSOncosec Medical IncNVHealthDrugPharmaceutical PreparationsO'Connor Daniel J.NJDOCEO,PS-51.960-3-466D
11/1/19 20:00
10/31/19
ONCSOncosec Medical IncNVHealthDrugPharmaceutical PreparationsO'Connor Daniel J.NJDOCEO,PS-52.160-2-369D
11/7/18 12:08
11/7/18
ONCSOncosec Medical IncNVHealthDrugPharmaceutical PreparationsO'Connor Daniel J.NJDOCEO,PP90.91000106027D
2/6/18 09:15
2/5/18
ONCSOncosec Medical IncNVHealthDrugPharmaceutical PreparationsO'Connor Daniel J.CADOCEOP251.50017New17D
11/2/16 16:40
11/2/16
ADXSAdvaxis, Inc.DEHealthDrugPharmaceutical PreparationsO'Connor DanielNJDOCEOS-698.328-8-3295D172-3022-37-21-12-510-614-290
5/2/16 16:31
5/2/16
ADXSAdvaxis, Inc.DEHealthDrugPharmaceutical PreparationsO'Connor DanielNJOCEOS-627.517-8-3308D185-54-3913-6-15-18-11-2-81971
2/1/16 18:01
1/29/16
ADXSAdvaxis, Inc.DEHealthDrugPharmaceutical PreparationsO'Connor DanielNJOCEOS-616.889-9-3313D48-33-57-46-38-140-3-6-10-16112026
11/3/15 16:30
10/30/15
ADXSAdvaxis, Inc.DEHealthDrugPharmaceutical PreparationsO'Connor DanielNJOCEOS-10212.2612-8-2332D231289-30-19-232620-3514-3-50-45-33
8/4/15 16:30
7/31/15
ADXSAdvaxis, Inc.DEHealthDrugPharmaceutical PreparationsO'Connor DanielNJOCEOS-13015.4416-8-2339D38846465-12-24-15-13-33-5-11-27-56-27
4/2/14 06:09
3/31/14
ADXSAdvaxis, Inc.DEHealthDrugPharmaceutical PreparationsO'Connor DanielNJDOCEOP103.00131311D-80-74-44-30-42-33-363-1-4-1017393
10/29/13 19:31
10/24/13
ADXSAdvaxis, Inc.DEHealthDrugPharmaceutical PreparationsO'Connor DanielNJDOCEOP.a544.001142861D-80-32-5513-38-2517-1-1-220-31-15
10/28/13 21:30
10/24/13
ADXSAdvaxis, Inc.DEHealthDrugPharmaceutical PreparationsO'Connor DanielNJDOCEOP.d544.001142861D-80-37-588-43-21-2804-1131-34-10

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact